07/11/03

Savings for science: the case for open access

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Savings for science: the case for open access</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>Many have applauded the Public Library of Science’s launch of the open-access journal PLoS Biology last month. Soon PLoS Medicine will follow. But the PLoS ventured into publishing only because it failed to persuade the major players in the business to convert to open access.</P><br />
<P>In this article, Pritpal S. Tamber of BioMed Central and colleagues make the case for alternatives to the old subscription-based model of science publishing which, they say, is rife with problems. Not only do authors lose copyright, but it is costly and hurts science by excluding many researchers and leaving less money for the research itself.</P><br />
<P>The authors say PubMed Central’s new twist on the subscription-based model is a useful alternative. But they feel that the PLoS and BioMed Central are showing the real way forward by asking authors to pay for publication, where possible. It is, they say, not only a viable business model, but a big boost for the public good. </P><br />
<P><a  href="http://www.thelancet.com/journal/vol362/iss9395/full/llan.362.9395.editorial_and_review.27694.1" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to opinion article in <EM>The Lancet</EM></A><EM>* </EM></P><br />
<P>* Free registration is required to view this article.<EM> </EM></P><br />
<P>Reference: <em>The Lancet</em>, 362, 1575 (2003)</P></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/opinions/savings-for-science-the-case-for-open-access/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/opinions/savings-for-science-the-case-for-open-access/",null,true])
</script>
</div>

Many have applauded the Public Library of Science’s launch of the open-access journal PLoS Biology last month. Soon PLoS Medicine will follow. But the PLoS ventured into publishing only because it failed to persuade the major players in the business to convert to open access.

In this article, Pritpal S. Tamber of BioMed Central and colleagues make the case for alternatives to the old subscription-based model of science publishing which, they say, is rife with problems. Not only do authors lose copyright, but it is costly and hurts science by excluding many researchers and leaving less money for the research itself.

The authors say PubMed Central’s new twist on the subscription-based model is a useful alternative. But they feel that the PLoS and BioMed Central are showing the real way forward by asking authors to pay for publication, where possible. It is, they say, not only a viable business model, but a big boost for the public good.

Link to opinion article in The Lancet*

* Free registration is required to view this article.

Reference: The Lancet, 362, 1575 (2003)